SEC Filing Summary: N2OFF, Inc. (NITO)
Business Context and Reporting Period
This Form 8-K was filed on December 12, 2024, reporting events occurring on December 11, 2024. The registrant, N2OFF, Inc. (trading symbol NITO on The Nasdaq Capital Market), is an emerging growth company incorporated in Nevada with principal offices in Israel. The filing serves as a correction to a previous 8-K filed on December 10, 2024, regarding a private placement securities purchase agreement.
Key Financial Metrics
The filing does not provide standard financial statements, revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the aggregate gross proceeds from the Private Placement, which are approximately $1,500,000. The purchase price for the units is $0.24 per unit.
Material Changes and Corrections
The filing corrects specific terms regarding the Private Placement previously disclosed:
- Unit Composition Correction: The previous filing incorrectly stated that units consisted of one share of Common Stock and/or one and a half pre-funded warrants. The corrected terms state that each unit consists of (i) one share of Common Stock and/or one pre-funded warrant to purchase one share of Common Stock, and (ii) one and a half warrants to purchase one share of Common Stock.
- Issuance Timing: Clarification was added that units and underlying securities will not be issued to investors until fifteen calendar days after the listing of additional shares is submitted to The Nasdaq Capital Market LLC.
- Warrant Amendment: On December 11, 2024, the Common Warrant was amended to include a floor price for anti-dilution provisions. The floor price is set at not less than $0.048 (20% of the $0.24 purchase price). If the exercise price is reduced due to a dilutive issuance, it will be reduced to this floor price, and the number of warrant shares will be proportionately increased.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of general business risks. The primary contingency noted is the conditional issuance of securities, which is dependent on the submission of a listing application to The Nasdaq Capital Market LLC. The full text of the amended Common Warrant is filed as Exhibit 4.1.1.
Investor Verification Checklist
- Verify the corrected unit composition (1 share + 1 pre-funded warrant + 1.5 warrants) versus the previously reported terms.
- Confirm the $0.048 floor price mechanism for the Common Warrant anti-dilution provisions.
- Monitor the status of the listing application for additional shares on The Nasdaq Capital Market, as issuance is contingent upon this submission.
- Review the full text of the amended Common Warrant in Exhibit 4.1.1 for complete legal terms.